A prospective Canadian cohort study suggested that serious underlying arrhythmia was often identified within the first 2-hours of emergency department (ED) arrival for low-risk patients, and within 6-hours for medium- and high-risk patients. Outpatient cardiac rhythm monitoring for 15-days for selected medium-risk patients and all high-risk patients discharged from the hospital should also be considered. There were 5,581 patients (mean age 53.4 years, 54.5% females, 11.6% hospitalized) available for analysis, including 346 (6.2%) censored due to incomplete 30-day follow-up. 417 (7.5%) patients suffered serious outcomes of which 207 (3.7%) were arrhythmic (161 arrhythmias, 30 cardiac device implantations, 16 unexplained death). Overall, 4123 (73.9%) were classified as Canadian Syncope Risk Score low-risk, 1062 (19.0%) medium and 396 (7.1%) high-risk. The score accurately stratified subjects as low (0.4% risk for 30-day arrhythmic outcome), medium (8.7% risk) and high-risk (25.3% risk). One-half of arrhythmic outcomes were identified within 2-hours of ED arrival in low-risk and within 6-hours in medium and high-risk patients and the residual risk after these cut-points were 0.2% for low-risk, 5.0% medium and 18.1% high-risk patients. Overall, 91.7% of arrhythmic outcomes among medium and high-risk patients including all ventricular arrhythmias were identified within 15-days. None of the low-risk patients suffered ventricular arrhythmia or unexplained death while 0.9% medium-risk and 6.3% of high-risk patients suffered them. Source: https://www.ahajournals.org/
Children and adolescents who regularly consume sugar-sweetened beverages (SSBs) and fruit juice may face a…
Women who consistently performed resistance training had a substantially lower risk of major cardiovascular disease…
US Adults with prediabetes who participated in an intensive lifestyle intervention had a significantly lower…
The impact of late-life high blood pressure (BP) on dementia risk appears to depend on…
A U.S. study found that receiving the recombinant herpes zoster vaccine (RZV, shingles vaccine) was…
A pooled analysis of 11 prospective cohort studies involving more than 1.5 million adults found…
This website uses cookies.